21 June: The Global Day for Amyotrophic Lateral Sclerosis
Upcoming SlideShare
Loading in...5
×
 

21 June: The Global Day for Amyotrophic Lateral Sclerosis

on

  • 3,526 views

 

Statistics

Views

Total Views
3,526
Views on SlideShare
3,486
Embed Views
40

Actions

Likes
18
Downloads
40
Comments
12

2 Embeds 40

https://twitter.com 38
https://tweetdeck.twitter.com 2

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel

15 of 12 Post a comment

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
  • JohnCerebro, muchas gracias por tu comentario. La presentación la hice influenciada por un caso de ELA, el cual he vivido relativamente de cerca; relativamente, pero para darme cuenta lo insidiosa que es esta enfermedad. Al paciente le fue diagnosticada ela en agosto del año pasado. Cuando llegaron las férulas, se hizo ya petición de silla de ruedas; cuando se cuestionó que si traqueo o no, murió. Sólo deseaba llegar a julio para ver a sus nietos....murió en mayo. Ya se pueden ir tirando el agua helada por allí, si no hay dinero, no hay investigación. No hay dinero para el tratamiento de hepatitis C, no hay dinero para solucionar el problema de Ébola...eso sí, hay dinero para hacer guerras. Que si somos 'homo sapiens sapiens' !
    Un abrazo grande.
    Are you sure you want to
    Your message goes here
    Processing…
  • Sí, es una degeneración horrible. Yo he visto sólo tres casos, en veinte años y, como contratados, duraron dos años y un poco más, pese a todo lo que pudimos hacer o tratar de hacer, parálisis ascendente, milímetro a milímetro, con la lucidez conservada y, quizás, mucho más consciente. Tipos conscientes acerca de sus agonías y nosotros prolongamos esa agonía.
    Are you sure you want to
    Your message goes here
    Processing…
  • Gracias, Cachi. Sí, una enfermedad cruel, despiadada, insidiosa e implacable...
    Are you sure you want to
    Your message goes here
    Processing…
  • Muchas gracias, dear John.
    Are you sure you want to
    Your message goes here
    Processing…
  • Thank you, Eddie.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

21 June: The Global Day for Amyotrophic Lateral Sclerosis 21 June: The Global Day for Amyotrophic Lateral Sclerosis Presentation Transcript

  • 21 June: The Global Day for ALS ALS is a degenerative neurological disease that leads to progressive weakness. ALS does not discriminate on the basis of race, religion, nationality, gender, or economic status. The cause of ALS is still unknown and there is no cure...however, there is hope.
  • What is amyotrophic lateral sclerosis (ALS)? ALS, often referred to as Lou Gehrig's disease or motor neuron disease (MND)—is a progressive, degenerative disease affecting motor neurons. Motor neurons are specialized nerve cells that carry impulses from the brain to the muscles by way of the brainstem and the spinal cord. The muscles then move in response to these impulses. In ALS, motor neurons gradually cease functioning and die. As this happens, the muscle tissues waste away because no movement is being stimulated. This results in gradually worsening muscle weakness, atrophy and often spasticity. Only the motor neurons are affected. Other nerve cells, such as sensory neurons that bring information from sense organs to the brain, remain healthy.
  • Who gets ALS? ALS occurs throughout the world regardless of race, ethnicity or socioeconomic status. Men are affected slightly more frequently than women. It most commonly occurs between 40 and 70 years of age, although the disease can strike at any age. How Common is ALS in the United States? More than 5,600 Americans are diagnosed with ALS each year. Approximately 35,000 people at any given time are living with ALS in the United States. The incidence of ALS is close to that of multiple sclerosis and four times that of muscular dystrophy.
  • What are the symptoms of ALS? Some of the early symptoms of ALS might include: Weakness or poor coordination in one limb Changes in speaking or swallowing Unusual muscle twitches, spasms or cramps Unusual weight loss or loss of muscle bulk Typically, ALS affects motor neurons in both the brainstem and spinal cord. Symptoms related to the brainstem neurons (sometimes referred to as “bulbar symptoms”) can include spasticity or stiffness in the lower limbs, face or jaw. Feelings of heaviness, fatigue, stiffness and lack of coordination are common. Reflexes may be very brisk or exaggerated. Unprovoked outbursts of laughter or crying can occur, a condition often referred to as “pseudobulbar affect” or “emotional lability.” Symptoms related to the spinal cord neurons (sometimes referred to as “somatic symptoms”) can include weakness, muscle wasting or muscle twitching. It is important to remember that ALS strikes people in different ways. The symptoms and progression of the disease will be different from person to person.
  • How is ALS diagnosed? The diagnosis of ALS is a “clinical diagnosis,” meaning there is no specific test for it. Often, tests will be administered to rule out illnesses with similar symptoms. These may include an MRI of the brain or spinal cord, an electromyography (EMG) study of nerve and muscle function, and a variety of blood and urine tests. After reviewing these test results and the patient's medical history, and performing a complete neurological exam, a neuromuscular specialist can usually reach a diagnosis. It may take several months of observation and retesting to reach a definitive diagnosis and that diagnosis should be confirmed via a second opinion from another neuromuscular specialist.
  • What is the prognosis of ALS? ALS progresses at different rates in each individual. The average survival for someone affected by ALS is three to five years. Fifty percent of those affected pass away within five years of diagnosis. A small percentage may live 10 years or more. As the disease progresses, the patient usually experiences a decline in speech, swallowing and limb strength and function. Generally, ALS is not a physically painful condition, though discomfort can result from immobility and muscle shortening. The ALS patient usually remains alert and retains normal sensation, vision, bowel and bladder function. While most patients do not have loss of intellectual function, some may have subtle changes in mood, behavior or personality. In a small minority of patients, more significant changes in behavior and judgment suggest a form of dementia.
  • What causes ALS? Is ALS inherited? Approximately 10 percent of all ALS cases are inherited forms, known as “familial ALS.” Several genes have been identified that cause familial ALS. The remaining 90 percent of cases are called “sporadic ALS.” In 2011, researchers, funded in part by the Les Turner ALS Foundation, identified a common cause of all forms of ALS: a broken-down protein “recycling system” in the neurons of the spinal cord and brain. Additional research is needed to determine how best to treat this faulty pathway.
  • Is there any treatment for ALS? Many of the symptoms of ALS are treatable, but there are no drugs or treatments to cure the disease. However, patients may elect to take Rilutek©, the first FDA-approved medication for the treatment of ALS, as it has been shown to modestly increase lifespan. In addition, Nuedexta is approved by the FDA to treat pseudobulbar affect, a symptom that can occur in ALS/MND and other neurological conditions. Decisions regarding medication should be made in consultation with a neuromuscular specialist and should be part of a comprehensive treatment approach. The quality of life of patients with ALS can often be improved by various treatments and interventions. Care provided by experts in multidisciplinary centers has been shown to prolong survival (Miller, et. al., 2009). Proper positioning, exercise, physical therapy and medications can help patients manage their symptoms. A feeding tube may be suggested if there is inadequate nutrition, extended meal times, rapid weight loss, high risk of aspiration (inhaling food or liquids into the lungs) or recurrent pneumonia. A wide range of devices and techniques can address problems with communication. Ultimately, ALS may result in sleep interruptions and changes in breathing, requiring consideration of airway clearance therapies. This may range from medications to non-invasive (mask) ventilation to a tracheostomy with mechanical ventilation. Managing symptoms is often a full-time responsibility for the patient and their caregivers.
  • Life with ALS.....the World from a Different Angle
  • “I am quite often asked: How do you feel about having ALS? The answer is, not a lot. I try to lead as normal a life as possible, and not think about my condition, or regret the things it prevents me from doing, which are not that many.” - Stephen Hawking
  • end cast 21 June: The Global Day for Amyotrophic Lateral Sclerosis images credit www. Music Yanni created olga.e. thanks for watching